Improving life and health through next-generation science Novel Therapies for Metabolic and Endocrine Disorders🔒 SSL Verified
Live Data Status: |News & Media
Welcome to the detailed analysis for vikingtherapeutics.com. This domain is officially recognized as Home - Viking Therapeutics. According to their official web presence, their primary focus is: "Detailed SEO and authority metrics for vikingtherapeutics.com. Vikingtherapeutics currently holds an estimated domain authority score of 70/100 in the .COM namespace based on our global index mapping.".
- Tech Stack
- WordPress
- Link Profile
- Internal Pages: 76Outbound Links: 4
- Localization
- en
6-Month Traffic Trend Estimate
M1
M2
M3
M4
M5
M6
Estimated Market Value
$3,315
Based on domain age, authority, and keyword relevance.
TLD Availability Risk
- vikingtherapeutics.comTaken
- vikingtherapeutics.netTaken
- vikingtherapeutics.orgTaken
- vikingtherapeutics.ioTaken
- vikingtherapeutics.coTaken
- vikingtherapeutics.aiAvailable
Content Snippets from vikingtherapeutics.com
"Viking Therapeutics is a clinical-stage biotechnology company advancing a next-generation portfolio of therapies for obesity and metabolic disease. We are developing treatments to help patients achieve meaningful, lasting improvements in health by treating obesity first. Our therapies are designed to support the long-term health benefits of weight loss, including cardiovascular health, improved physical function, and quality of life."
"We view obesity as a chronic disease and believe that treating it first is a priority to supporting broader, long-term benefits and a healthier life."
"At the center of our pipeline is VK2735, a dual GLP-1/GIP receptor agonist with the potential to be the first dual agonist available in both oral and injectable formulations. VK2735 has demonstrated compelling efficacy in clinical trials and is now in Phase 3 obesity studies. With its unique dosing and administration options, it may offer flexible treatment from initial weight loss to ongoing management designed to support patients in improving overall health."
"Beyond VK2735, Viking is advancing additional programs targeting metabolic and liver diseases, including VK2809, as well as next-generation approaches for obesity, such as amylin-based therapies."
Key Topics & Focus Areas for vikingtherapeutics.com:
Treat Obesity First
By comparing vikingtherapeutics.com to other leading websites in its niche, marketers and researchers can identify key traffic sources and growth opportunities. Explore our related resources below to find websites similar to vikingtherapeutics.com.
Frequently Asked Questions
Is vikingtherapeutics.com a safe and secure website?
Yes, according to our latest analysis, we detected a valid SSL certificate ensuring a secure connection.
What is the authority score of vikingtherapeutics.com?
As of August 4, 2026, vikingtherapeutics.com holds an estimated domain authority score of 65/100 based on our VisitRank tracking algorithms.
What are the top alternatives to vikingtherapeutics.com?
You can find the best alternatives and similar sites to vikingtherapeutics.com in our explore section, which includes competitors in the News & Media sector.
Data Sources & Methodology: DNS telemetry and routing records are resolved via live root servers. Market valuation estimates are computed algorithmically based on proprietary historical indexation multiples and standardized digital asset appraisal methodologies.
Common Misspellings & Typo Domains for vikingtherapeutics.com:
vkiingtherapeutics.comviingtherapeutics.comviikingtherapeutics.comvokingtherapeutics.comvikongtherapeutics.comvikingtharapeutics.comvikingtherepeutics.comvikingtherapautics.comvikingtherapeotics.comvikingtherapeutocs.com